Related Experiment Video

Updated: Aug 9, 2025

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.0K

[Potential therapeutic implication of focal adhesion kinase in small-cell lung cancer]

C Decouvreur1, M Lecocq2, C Pilette3

  • 1Université catholique de Louvain (UCLouvain), institut de recherche expérimentale et clinique (IREC), pôle de pneumologie (PNEU), Bruxelles, Belgique; UCLouvain, CHU UCL Namur (site de Godinne), service de pneumologie, Namur, Belgique.

Revue Des Maladies Respiratoires
|February 24, 2023
PubMed

Insights

Focal Adhesion Kinase (FAK) drives small cell lung cancer (SCLC) invasion. Inhibiting FAK shows potential as a targeted therapy for SCLC, offering new hope for this aggressive cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Context:

  • Small cell lung cancer (SCLC) lacks targeted therapies due to poorly understood molecular progression.
  • Focal Adhesion Kinase (FAK) activation is linked to SCLC invasiveness in vitro.

Purpose:

  • To investigate the role of FAK in SCLC development and progression.
  • To evaluate the therapeutic potential of FAK inhibition in SCLC using a novel mouse model.

Summary:

  • This study establishes a mouse model to explore FAK's function in SCLC.
  • Results indicate FAK inhibition as a promising antitumoral strategy for SCLC in vivo.

Impact:

  • Provides a new preclinical model for SCLC research.
  • Highlights FAK as a potential therapeutic target for improving SCLC patient outcomes.
Keywords:
Cancer pulmonaire à petites cellulesFocal Adhesion KinaseInhibiteur de tyrosine kinaseKinase de l’Adhérence Focale.Small-cell lung cancerTyrosine kinase inhibitor.

More Related Videos

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

9.3K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.3K

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K